Perianal fistulas mimicking Crohn's disease in HIV-infected male patient

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 793-794

  Rivera, Margherita ^a   Angelucci, Erika ^a   Crispino, Pietro ^a   Pronio, Anna Maria ^a   Marcheggiano, Adriana ^a   Vernia, Piero ^a   Badiali, Danilo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; METRONIDAZOLE;

ADULT; ANUS FISTULA; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; CROHN DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; MALE; PRIORITY JOURNAL;

ADULT; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, GASTROINTESTINAL; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; MALE; RECTAL FISTULA;

EID: 61949123573     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.98     Document Type: Letter

References (10)

1. Nadal SR, Manzione CL, Galvao VM et al. Perianal disease in HIV positive patients compared with a seronegative population. Dis Colon Rectum 1999;42:649-45.
2. Manookian CM, Sokol TP, Headrick C et al. Does HIV status in: uence the anatomy of anal fistulas. Dis Colon Rectum 1998;41:1529-33.
3. Rintamaki LS, Davis TC, Skripkauskas S et al. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS 2006;20:359-68.
4. Rao D, Kekwaletswe TC, Hosek S et al. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care 2007;19:28-33.
5. Forrester B, Pawade J, Horner P. The potential role of serology in diagnosing chronic lynphogranuloma venereum (LGV): a case of LGV mimicking Crohn's disease. Sex Transm Infect 2006;82:139-47.
6. Kotler DP. HIV infection and the gastrointestinal tract. AIDS 2005;19:107-17.
7. Vyakarnam A, Meatar P, Meager A et al. Altered production of tumor necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol 1991;84:109-15.
8. Eylar EH, Lefranc CE, Yamamura Y et al. HIV infection and aging: enhanced interferon- and tumor necrosis factor alpha production by the CD+CD28- T subset. BMC Immunol 2001;2:10-21.
9. Beltran B, Nos P, Bastida G et al. Safe and effective application of anti-TNF alpha in patients infected with HIV and concomitant Crohn's disease. Gut 2006;55:1670-1.
10. Cepeda EJ, Williams FM, Ishimori ML et al. The use of anti-Tumor Necrosis Factor therapy in HIV positive individuals with rheumatic disease. Ann Rheum Dis 2008;67:710-2